Home/Filings/4/0001179110-21-000065
4//SEC Filing

Seim Robin Gene 4

Accession 0001179110-21-000065

CIK 0000926326other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:18 PM ET

Size

5.8 KB

Accession

0001179110-21-000065

Insider Transaction Report

Form 4
Period: 2021-01-04
Seim Robin Gene
V.P., Finance & CFO
Transactions
  • Sale

    Common Stock

    2021-01-04$119.62/sh1,319$157,77935,558 total
Holdings
  • Common Stock

    36,877
Footnotes (2)
  • [F1]The price reported in Column 4 is the exact price of $119.62. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on August 17, 2020.

Issuer

OMNICELL, Inc

CIK 0000926326

Entity typeother

Related Parties

1
  • filerCIK 0001351911

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:18 PM ET
Size
5.8 KB